| Risk assessment, prognosis and guideline implementation in pulmonary arterial hypertension A Boucly, J Weatherald, L Savale, X Jaïs, V Cottin, G Prevot, F Picard, ... European Respiratory Journal 50 (2), 2017 | 674 | 2017 |
| Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension J Weatherald, A Boucly, D Chemla, L Savale, M Peng, M Jevnikar, X Jaïs, ... Circulation 137 (7), 693-704, 2018 | 174 | 2018 |
| Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation A Beurnier, EM Jutant, M Jevnikar, A Boucly, J Pichon, M Preda, M Frank, ... European Respiratory Journal 56 (5), 2020 | 126 | 2020 |
| Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension A Boucly, V Cottin, H Nunes, X Jaïs, A Tazi, G Prévôt, M Reynaud-Gaubert, ... European Respiratory Journal 50 (4), 2017 | 126 | 2017 |
| Aztreonam plus clavulanate, tazobactam, or avibactam for treatment of infections caused by metallo-β-lactamase-producing Gram-negative bacteria C Emeraud, L Escaut, A Boucly, N Fortineau, RA Bonnin, T Naas, L Dortet Antimicrobial agents and chemotherapy 63 (5), 10.1128/aac. 00010-19, 2019 | 115 | 2019 |
| Association between initial treatment strategy and long-term survival in pulmonary arterial hypertension A Boucly, L Savale, X Jaïs, F Bauer, E Bergot, L Bertoletti, A Beurnier, ... American journal of respiratory and critical care medicine 204 (7), 842-854, 2021 | 112 | 2021 |
| External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry A Boucly, J Weatherald, L Savale, P De Groote, V Cottin, G Prévot, ... European Respiratory Journal 59 (6), 2022 | 108 | 2022 |
| Haemodynamics and serial risk assessment in systemic sclerosis associated pulmonary arterial hypertension J Weatherald, A Boucly, D Launay, V Cottin, G Prévot, D Bourlier, ... European Respiratory Journal 52 (4), 2018 | 87 | 2018 |
| Acute decompensated pulmonary hypertension L Savale, J Weatherald, X Jaïs, C Vuillard, A Boucly, M Jevnikar, ... European Respiratory Review 26 (146), 2017 | 71 | 2017 |
| Prevalence of pulmonary embolism in patients with COVID-19 at the time of hospital admission M Jevnikar, O Sanchez, R Chocron, M Andronikof, M Raphael, ... European Respiratory Journal 58 (1), 2021 | 67 | 2021 |
| Predictors of survival in patients with not-operated chronic thromboembolic pulmonary hypertension YU Taniguchi, X Jaïs, M Jevnikar, A Boucly, J Weatherald, P Brenot, ... The Journal of Heart and Lung Transplantation 38 (8), 833-842, 2019 | 67 | 2019 |
| Association between BMI and obesity with survival in pulmonary arterial hypertension J Weatherald, A Huertas, A Boucly, C Guignabert, Y Taniguchi, Y Adir, ... Chest 154 (4), 872-881, 2018 | 60 | 2018 |
| The low-risk profile in pulmonary arterial hypertension. Time for a paradigm shift to goal-oriented clinical trial endpoints? J Weatherald, A Boucly, S Sahay, M Humbert, O Sitbon American journal of respiratory and critical care medicine 197 (7), 860-868, 2018 | 55 | 2018 |
| Comparative safety and tolerability of prostacyclins in pulmonary hypertension C O’Connell, D Amar, A Boucly, L Savale, X Jaïs, MC Chaumais, ... Drug safety 39, 287-294, 2016 | 44 | 2016 |
| Clinical pharmacology of endothelin receptor antagonists used in the treatment of pulmonary arterial hypertension MC Chaumais, C Guignabert, L Savale, X Jaïs, A Boucly, D Montani, ... American Journal of Cardiovascular Drugs 15, 13-26, 2015 | 41 | 2015 |
| Using the plasma proteome for risk stratifying patients with pulmonary arterial hypertension CJ Rhodes, J Wharton, EM Swietlik, L Harbaum, B Girerd, JG Coghlan, ... American Journal of Respiratory and Critical Care Medicine 205 (9), 1102-1111, 2022 | 38 | 2022 |
| Serum and pulmonary uric acid in pulmonary arterial hypertension L Savale, S Akagi, L Tu, A Cumont, R Thuillet, C Phan, B Le Vely, ... European Respiratory Journal 58 (2), 2021 | 36 | 2021 |
| Risk stratification in pulmonary arterial hypertension J Weatherald, A Boucly, O Sitbon Current Opinion in Pulmonary Medicine 24 (5), 407-415, 2018 | 29 | 2018 |
| Intensity and quality of exertional dyspnoea in patients with stable pulmonary hypertension A Boucly, C Morélot-Panzini, G Garcia, J Weatherald, X Jaïs, L Savale, ... European Respiratory Journal 55 (2), 2020 | 28 | 2020 |
| The evolving landscape of pulmonary arterial hypertension clinical trials J Weatherald, A Boucly, A Peters, D Montani, K Prasad, MA Psotka, ... The Lancet 400 (10366), 1884-1898, 2022 | 27 | 2022 |
